hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway
The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
hTERT is the catalytic subunit of the telomerase and is hence required for telomerase maintenance activity and cancer cell immortalization. Here, we show that acute hTERT depletion has no adverse effects on the viability or proliferation of cervical and colon carcinoma cell lines, as evaluated within 72 h after transfection with hTERT-specific small interfering RNAs (siRNAs). Within the same time frame, hTERT depletion facilitated the induction of apoptotic cell death by cisplatin, etoposide, mitomycin C and reactive oxygen species, yet failed to sensitize cells to death induction via the CD95 death receptor. Experiments performed with p53 knockout cells or chemical p53 inhibitors revealed that p53 was not involved in the chemosensitizing effect of hTERT knockdown. However, the proapoptotic Bcl-2 family protein Bax was involved in cell death induction by hTERT siRNAs. Depletion of hTERT facilitated the conformational activation of Bax induced by genotoxic agents. Moreover, Bax knockout abolished the chemosensitizing effect of hTERT siRNAs. Inhibition of mitochondrial membrane permeabilization by overexpression of Bcl-2 or expression of the cytomegalovirus-encoded protein vMIA (viral mitochondrial inhibitor of apoptosis), which acts as a specific Bax inhibitor, prevented the induction of cell death by the combination of hTERT depletion and chemotherapeutic agents. Altogether, our data indicate that hTERT inhibition may constitute a promising strategy for facilitating the induction of the mitochondrial pathway of apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, hTERT protein acts on mitochondria to inhibit the intrinsic pathway of apoptosis, 129”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [129]
In the citing paper
“and interacts with chromatin remodeling factors (such as SMARCA4) and transcription factors (such as NF-kB) to transactivate genes involved in tumor progression.129”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [129]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“…inactivate the p53 pathway that links the DNA-damage response to mitochondrial apoptosis, either through transcriptional effects of p53 or owing to a physical interaction of p53 with proapoptotic members of the Bcl-2 family (Vogelstein et al., 2000; Vousden and Lu, 2002; Perfettini et al., 2004).”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Self-citationLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Switching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Movement of Bax from the Cytosol to Mitochondria during Apoptosis
Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., & Youle, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1281 · Cited by 1,806
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1661 · Cited by 1,166
Self-citationThe CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · cited 1×
“Wild-type, p53 knockout (Bunz et al., 1999) and Bax knockout HCT116 cells (Zhang et al., 2000) were cultured in the same conditions, with the only difference that DMEM was replaced by McCoy’s 5A medium.”
MethodDePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951 · cited 1×
“…express telomerase, an enzyme that can add telomeric repeats onto chromosome terminal repeats, and thus avoids the ‘telomere problem’, a biological clock that limits the lifespan of normal, telomerase-negative somatic cells owing to progressive erosion of telomeres (DePinho, 2000; Blackburn, 2001).”
BackgroundRole of BAX in the Apoptotic Response to Anticancer Agents
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., & Vogelstein, B. (2000) · Science · doi:10.1126/science.290.5493.989 · Cited by 863 · cited 1×
“Wild-type, p53 knockout (Bunz et al., 1999) and Bax knockout HCT116 cells (Zhang et al., 2000) were cultured in the same conditions, with the only difference that DMEM was replaced by McCoy’s 5A medium.”
MethodIdentification of essential genes in cultured mammalian cells using small interfering RNAs
Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T., & Weber, K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.24.4557 · Cited by 829
Telomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Efficient delivery of siRNA for inhibition of gene expression in postnatal mice
Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A., & Herweijer, H. (2002) · Nature Genetics · doi:10.1038/ng944 · Cited by 546
Telomerase modulates expression of growth-controlling genes and enhances cell proliferation
Smith, L. L., Coller, H. A., & Roberts, J. M. (2003) · Nature Cell Biology · doi:10.1038/ncb985 · Cited by 438 · cited 1×
“This effect involves altera- tions in the transcriptome (Smith et al., 2003; Li et al., 2005) as well as in chromatin structure (Masutomi et al., 2005) that are unrelated to the shortening of telomeres, suggesting that hTERT may have other functions than telomere maintenance.”
BackgroundTelomerase contributes to tumorigenesis by a telomere length-independent mechanism
Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182407599 · Cited by 431 · cited 1×
“It has been suspected for long that hTERT may contribute to tumorigenesis by a telomere lengthindependent mechanism because mutant hTERT, incapable of maintaining telomere length, can transform cell lines in vitro (Stewart et al., 2002).”
BackgroundGoldmacher, V. S., Bartle, L. M., Skaletskaya, A., Dionne, C. A., Kedersha, N. L., Vater, C. A., Han, J.-W., Lutz, R. J., Watanabe, S., McFarland, E. D. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12536 · Cited by 423
Chemotherapy: targeting the mitochondrial cell death pathway
Debatin, K.-M., Poncet, D., & Kroemer, G. (2002) · Oncogene · doi:10.1038/sj.onc.1206039 · Cited by 396
Self-citationHaendeler, J., Hoffmann, J., Diehl, J. F., Vasa, M., Spyridopoulos, I., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000121104.05977.f3 · Cited by 384
The telomerase reverse transcriptase regulates chromatin state and DNA damage responses
Masutomi, K., Possemato, R., Wong, J. M. Y., Currier, J. L., Tothova, Z., Manola, J. B., Ganesan, S., Lansdorp, P. M., Collins, K., & Hahn, W. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503095102 · Cited by 382
Castedo, M., Hirsch, T., Susin, S. A., Zamzami, N., Marchetti, P., Macho, A., & Kroemer, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.512 · Cited by 349
Self-citationMitochondrial hTERT exacerbates free‐radical‐mediated mtDNA damage
Santos, J. H., Meyer, J. N., Skorvaga, M., Annab, L. A., & Van Houten, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00124.x · Cited by 264
Telomerase-Specific Replication-Selective Virotherapy for Human Cancer
Kawashima, T., Kagawa, S., Kobayashi, N., Shirakiya, Y., Umeoka, T., Teraishi, F., Taki, M., Kyo, S., Tanaka, N., & Fujiwara, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1075-3 · Cited by 262
Quantitation of mitochondrial alterations associated with apoptosis
Castedo, M., Ferri, K., Roumier, T., Métivier, D., Zamzami, N., & Kroemer, G. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00069-8 · Cited by 260
Self-citationXu, D., Wang, Q., Gruber, A., Björkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., & Pisa, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203890 · Cited by 257
Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J. C., & Perucho, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190210897 · Cited by 242
TERT regulates cell survival independent of telomerase enzymatic activity
Cao, Y., Li, H., Deb, S., & Liu, J.-P. (2002) · Oncogene · doi:10.1038/sj.onc.1205419 · Cited by 214
Belzacq, A.-S., El Hamel, C., Vieira, H. L. A., Cohen, I., Haouzi, D., Métivier, D., Marchetti, P., Brenner, C., & Kroemer, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204953 · Cited by 194
Self-citationLi, S., Rosenberg, J. E., Donjacour, A. A., Botchkina, I. L., Hom, Y. K., Cunha, G. R., & Blackburn, E. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0953 · Cited by 194
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
Castedo, M., Roumier, T., Blanco, J., Ferri, K. F., Barretina, J., Tintignac, L. A. J., Andréau, K., Perfettini, J., Amendola, A., Nardacci, R., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf391 · Cited by 165
Self-citationApoptosis in cancer—implications for therapy
Schulze‐Bergkamen, H., & Krammer, P. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.006 · Cited by 163
Li, S., Crothers, J., Haqq, C. M., & Blackburn, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502782200 · Cited by 158
hTERT antagonizes p53-induced apoptosis independently of telomerase activity
Rahman, R., Latonen, L., & Wiman, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208232 · Cited by 158
Haendeler, J., Hoffmann, J., Rahman, S., Zeiher, A. M., & Dimmeler, S. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00058-9 · Cited by 154
Jiang, F., Bao, J., Li, P., Nicosia, S. V., & Bai, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410395200 · Cited by 152
Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function
Bufalo, D. D., Rizzo, A., Trisciuoglio, D., Cardinali, G., Torrisi, M. R., Zangemeister‐Wittke, U., Zupi, G., & Biroccio, A. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401670 · Cited by 149
Kang, H. J., Choi, Y. S., Hong, S.-B., Kim, K.-W., Woo, R.-S., Won, S. J., Kim, E. J., Jeon, H. K., Jo, S.-Y., Kim, T. K., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4082-03.2004 · Cited by 138
An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria
Poncet, D., Larochette, N., Pauleau, A.-L., Boya, P., Jalil, A.-A., Cartron, P.-F., Vallette, F., Schnebelen, C., Bartle, L. M., Skaletskaya, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308408200 · Cited by 124
Self-citationLin, T.-Y., Huang, X., Gu, J. H., Zhang, L., Roth, J. A., Xiong, M., Curley, S. A., Yu, Y., Hunt, K. K., & Fang, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205926 · Cited by 110
Takakura, M., Kyo, S., Inoue, M., Wright, W. E., & Shay, J. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8037-8043.2005 · Cited by 107 · cited 1×
“Several oncogenes including c-Myc and c-Jun induce hTERT expression (Takakura et al., 2005), whereas the tumor suppressor p53 reduces hTERT expression (Xu et al., 2000).”
BackgroundLuiten, R. M., Pène, J., Yssel, H., & Spits, H. (2003) · Blood · doi:10.1182/blood-2002-07-2018 · Cited by 105
Folini, M., Brambilla, C., Villa, R., Gandellini, P., Vignati, S., Paduano, F., Daidone, M. G., & Zaffaroni, N. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.002 · Cited by 98
Zhang, P., Chan, S. L., Fu, W., Mendoza, M., & Mattson, M. P. (2003) · The FASEB Journal · doi:10.1096/fj.02-0603fje · Cited by 96
Fatal liaisons of p53 with Bax and Bak
Perfettini, J., Kroemer, R. T., & Kroemer, G. (2004) · Nature Cell Biology · doi:10.1038/ncb0504-386 · Cited by 88
Self-citationTelomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions
Lantuéjoul, S., Soria, J., Morat, L., Lorimier, P., Moro‐Sibilot, D., Sabatier, L., Brambilla, C., & Brambilla, E. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1376 · Cited by 87
Self-citationTelomerase as a therapeutic target for malignant gliomas
Komata, T., Kanzawa, T., Kondo, Y., & Kondo, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205072 · Cited by 85
Uziel, O., Fenig, E., Nordenberg, J., Beery, E., Reshef, H., Sandbank, J., Birenbaum, M., Bakhanashvili, M., Yerushalmi, R., Luria, D., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602592 · Cited by 83
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70 · cited 1×
“RNA interference of hTERT expression was performed using specific siRNA sequences for targeting hTERT mRNA, named hTERT siRNA1 (sense strand, 50-rgrArArCrGrgrgrgrCr CrUrgrgrArArCrCrArUArTT-30) and hTERT siRNA2 (sense strand, 50-rUrUrUrCrArUrCrArgrgrAgArgrUrUrUrgrgr ATT-30) (Masutomi et al., 2003).”
MethodCell death suppression by cytomegaloviruses
Goldmacher, V. S. (2005) · APOPTOSIS · doi:10.1007/s10495-005-0800-z · Cited by 68
Therapeutic Efficacy of PUMA for Malignant Glioma Cells Regardless of p53 Status
Ito, H., Kanzawa, T., Miyoshi, T., Hirohata, S., Kyo, S., Iwamaru, A., Aoki, H., Kondo, Y., & Kondo, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.685 · Cited by 64
Telomerase protects developing neurons against DNA damage-induced cell death
Lu, C., Fu, W., & Mattson, M. P. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00237-1 · Cited by 64
Gorbunova, V., Seluanov, A., & Pereira-Smith, O. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212944200 · Cited by 56
Jacob, D., Davis, J. J., Zhang, L., Zhu, H., Teraishi, F., & Fang, B. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700773 · Cited by 38
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor
Wu, P., Li, M., Wang, H., Zhou, J., Xu, G., Wang, S., Xi, L., Chen, G., Wang, B., Zhu, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.039 · Cited by 34
Telomerase Activity in Cervical Smears
Saretzki, G. C., Fischer, H., Kaufmann, I., Schewe, C., Nadjari, B., Blohmer, J., & Hauptmann, S. (2001) · Analytical Cellular Pathology · doi:10.1155/2001/630972 · Cited by 7
Cited by
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Self-citationAhmed, S., Passos, J. F., Birket, M. J., Beckmann, T., Brings, S., Peters, H., Birch-Machin, M. A., von Zglinicki, T., & Saretzki, G. (2008) · Journal of Cell Science · doi:10.1242/jcs.019372 · Cited by 491
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?
Passos, J. F., Saretzki, G., & von Zglinicki, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm893 · Cited by 344
Metadata
- Authors
- Massard, C., Zermati, Y., Pauleau, A.-L., Larochette, N., Métivier, D., Sabatier, L., Kroemer, G., & Soria, J.-C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Kroemer, G
- Soria, J-C
- Venue
- Oncogene
- Published
- 2006-04-17
- Volume
- 25
- Issue
- 33
- Pages
- 4505-4514
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1486872926
- Cited by
- 144
- References
- 57
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 12 · 2013: 17 · 2012: 11
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-01-24)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Ligue Contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- hTERT, telomerase, mitochondrial apoptosis, Bax, Bcl-2 family proteins, p53, chemosensitization, reactive oxygen species, mitochondrial membrane permeabilization, cervical cancer, colon cancer, siRNA knockdown
- MeSH terms
- Antineoplastic Agents, Cell Survival, Uterine Cervical Neoplasms, Cisplatin, Colonic Neoplasms, DNA-Binding Proteins, Etoposide, Female, Humans, Mitochondria, Mitomycin, Apoptosis, Reactive Oxygen Species, fas Receptor, Telomerase, Catalytic Domain, Cell Line, Tumor, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.